NEWS
See the latest PIR International News, Articles and Network Updates.
Richard Bungay – BioLeader Interview
Chief Executive Offer, Imophoron (November 2023) Richard was appointed as Chief Executive Officer of Imophoron in November 2022. Formerly, he was Chief Executive Officer of AIM-listed Diurnal Group plc, where he led the sale of the company to Neurocrine Biosciences [...]
Sven Kili – BioLeader Interview
Cell & Gene Therapy Specialist and Board Member (October 2023) Dr Sven Kili, is Principal at Sven Kili Consulting Ltd. where he provides specialist strategic consulting services to innovative Cell & Gene Therapy companies. His clients include small and [...]
2025 EU/UK Biotech Board Remuneration & Diversity Study
PIR International’s 2025 EU/UK Biotech Board Remuneration & Diversity Study is a data-driven resource that empowers executives, investors and the boardroom with the insights they need to improve board governance, top-level business decisions and truly excel. This strictly independent, [...]
EU/UK Biotech C-Suite Remuneration & Diversity Study
PIR International’s EU/UK Biotech C-Suite Remuneration & Diversity Study is a data-driven resource that empowers executives, investors and the boardroom with the insights they need to improve board governance, top-level business decisions and truly excel. This strictly independent, anonymised [...]